Overview
- The ruling holds the University Hospital of Pisa liable after the patient underwent nearly four years of chemotherapy, corticosteroids and steroids for a MALT-type lymphoma she did not have.
- An appellate panel raised compensation from €295,000 to €470,000 after revising the disability rating from 40% to 60%.
- A court-appointed expert report found no evidence to support the lymphoma diagnosis and deemed the treatments unnecessary and harmful.
- A second opinion in Genoa in 2011, including new biopsies, concluded the patient had no cancer.
- The hospital maintained its clinicians acted appropriately given a complex clinical picture, but the court prioritized the expert findings and documented physical, psychological and professional harm, including reduced work capacity and a temporary loss of her driving license.